Compare VMI & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VMI | RGEN |
|---|---|---|
| Founded | 1946 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.0B | 8.1B |
| IPO Year | 1994 | 1995 |
| Metric | VMI | RGEN |
|---|---|---|
| Price | $430.00 | $126.50 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 11 |
| Target Price | ★ $487.00 | $173.09 |
| AVG Volume (30 Days) | 151.7K | ★ 767.3K |
| Earning Date | 01-01-0001 | 05-27-2026 |
| Dividend Yield | ★ 0.64% | N/A |
| EPS Growth | N/A | ★ 286.96 |
| EPS | ★ 16.79 | 0.86 |
| Revenue | ★ $3,169,556,000.00 | $141,236,000.00 |
| Revenue This Year | $5.28 | $14.11 |
| Revenue Next Year | $5.42 | $14.71 |
| P/E Ratio | ★ $25.25 | $139.37 |
| Revenue Growth | 14.52 | ★ 35.10 |
| 52 Week Low | $250.07 | $102.97 |
| 52 Week High | $487.58 | $175.77 |
| Indicator | VMI | RGEN |
|---|---|---|
| Relative Strength Index (RSI) | 39.41 | 38.99 |
| Support Level | $401.25 | $113.07 |
| Resistance Level | $487.58 | $132.51 |
| Average True Range (ATR) | 14.19 | 6.58 |
| MACD | -5.40 | -0.04 |
| Stochastic Oscillator | 27.54 | 42.69 |
Valmont Industries Inc, along with its subsidiaries, operates as a manufacturer of products and services for infrastructure and agriculture markets. Its reportable segments are Infrastructure and Agriculture. The company generates maximum revenue from the Infrastructure segment, which includes the manufacturing and distribution of products and solutions to serve the infrastructure markets of utility, solar, lighting, transportation, and telecommunications, along with coatings services to protect metal products. The Agriculture segment provides irrigation equipment components, including aftermarket parts and tubular products, and technology solutions for precision agriculture. Geographically, it derives key revenue from the United States, followed by Australia, Brazil, and other regions.
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.